Skip to main content
OpenTrials
Completed

NCT Number: NCT02543762

Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease

To assess the feasibility and effectiveness of a program in L-IBD patients using CE targeted biopsies

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Gastroenteroly Department, Hospital Clinic, Barcelona, Spain

Loading trial locations.

About this study

We aim to know the prevalence and incidence of dysplasia and colitis-associated colorectal cancer in patients with longstanding colonic inflammatory bowel disease (N-IBD), in Spain and the usefulness of advanced endoscopy (chromoendoscopy) for the diagnosis and endoscopic differential diagnosis of N-IBD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of UC or colitis EC corroborated by clinical and histology
  • involvement of at least one third of the colon in patients with CD
  • involvement proximal to the rectum in patients with UC
  • Duration of disease > 10 years
  • No clinical activity:
  • May Score <6
  • CDEIS <3.5

Exclusion criteria

  • Personal history of CRC
  • colectomy
  • coagulopathy
  • refusal to participate in the study
  • known allergy to indigo carmine
  • colonoscopy in the last 6 months

Treatment and study plan

chromoendoscopy

Procedure

Chromoendoscopy involves the topical application of stains to improve tissue localization and characterization of lessions during endoscopy . Chromoendoscopy has been used in patients undergoing colonoscopy, including those undergoing surveillance for chronic ulcerative colitis. Using pit pattern classifications, chromoendoscopy has a high sensitivity and specificity for differentiating neoplastic from non-neoplastic lesions

Primary outcomes

  1. Prevalence and incidence of dysplasia and colitis-associated colorectal cancer in patients with longstanding colonic inflammatory bowel disease (N-IBD), in Spain

    Time frame: two year

    see title

Secondary outcomes

  1. Usefulness of advanced endoscopy in displasia characterization (chromoendoscopy ) for the diagnosis and endoscopic differential diagnosis of NIBD.

    Time frame: two year

    see title

Sponsors and collaborators

Lead sponsor

Hospital Clinic of Barcelona

Other

Collaborators

  • Complejo Hospitalario Universitario de Vigo
  • Complexo Hospitalario de Ourense
  • Hospital General de Mostoles
  • Hospital Universitari de Bellvitge
  • Hospital Universitario 12 de Octubre
  • Hospital Universitario Doctor Peset
  • Hospital Universitario La Fe
  • Hospital Universitario Ramon y Cajal
  • Hospital Universitario de Canarias
  • Hospital de Calella
  • Hospital de Manresa
  • Hospital de Sant Pau
  • Hospital del Mar
  • Puerta de Hierro University Hospital

Registry information

Acronym: CE

Important dates

Study start
2012
Primary completion
2014
Study completion
2015
First posted
Sep 7, 2015
Registry last updated
Sep 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.